Owner Choongwae Pharma Corporation

Inventors Kim, Daehoon; Ha, Jongryul; Kahn, Michael; Oh, Sewoong; Hojjati-Emami, Katayoon

Agent Davies Collison Cave

Pub. Number AU-B-2004268647

PCT Pub. Number WO2005/021025

Priority 60/498,451 28.08.03 US

Filing date 27 August 2004

Wipo publication date 10 March 2005

Acceptance publication date 1 July 2010

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/00 (2006.01)

A61K 31/4985 (2006.01) - Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems

A61K 31/5025 (2006.01) - ortho- or peri-condensed with heterocyclic ring systems

A61K 31/53 (2006.01) - having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

C07D 519/00 (2006.01) Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12Q 1/02 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving viable micro-organisms

C12Q 1/18 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - Testing for antimicrobial activity of a material

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine